Cobo, M.F.L.* et al. Single cell identification of defined ebv epitope-specific TCR alpha beta pairs for adoptive T cell transfer against EBV infection and EBV-associated malignancies. Bone Marrow Transplant. 54, 177-178 (2019)
Freudenreich, M.* et al. Clinical relevance of in vitro generation of dendritic cells of leukemic origin to predict response to immunotherapy in patients with AML and MDS. Bone Marrow Transplant. 54, 145-145 (2019)
Ritter, I.* et al. T-cell receptor deep sequencing analysis of EBV specific T cells before and after adoptive transfer in a patient after allogeneic stem cell transplantation. Bone Marrow Transplant. 50, S400 (2015)
Klar, R.* et al. Immunoproteomic identification of naturally presented epitopes presented on primary myeloid leukaemia cells and their potential as targets for T-cell receptor gene modified donor lymphocyte infusions. Bone Marrow Transplant. 48, S74-S75 (2013)
Burdach, S.* et al. Total body MRI-governed involved compartment irradiation combined with high-dose chemotherapy and stem cell rescue improves long-term survival in Ewing tumor patients with multiple primary bone metastases. Bone Marrow Transplant. 45, 483-489 (2010)
Buhmann, R. et al. Immunotherapy of recurrent B-cell malignancies after allo-SCT with Bi20 (FBTA05), a trifunctional anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion. Bone Marrow Transplant. 43, 383-397 (2009)
Zorn, J. ; Herber, M. ; Schwamberger, S. ; Adler, H. & Kolb, H.-. Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion. Bone Marrow Transplant. 41, S127-S128 (2008)
Munker, R.* ; Schmid, C.* ; Madrigal, J.A.* & Kolb, H.-J. An update on graft-versus-host and graft-versus-leukemia reactions: A summary of the sixth International Symposium held in Schloss Elmau. Bone Marrow Transplant. 34, 767-780 (2004)
Munker, R.* ; Günther, W. & Kolb, H.-J. New concepts about graft-versus-host and graft-versus-leukaemia-reactions : a summary of the 5. International Symposium in Munich. Bone Marrow Transplant. 30, 549-556 (2002)
Pihusch, R.* et al. The impact of antithymocyte globulin on short-term toxicity after allogenic stem cell transplantation. Bone Marrow Transplant. 30, 347-354 (2002)
Pihusch, R.* et al. Flow cytometric findings in platelets of patients following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 30, 381-387 (2002)
Holler, E. et al. Prognostic significance of increased IL-10 production in patients prior to allogenic bone marrow transplantation. Bone Marrow Transplant. 25, 237-241 (2000)
Pohla, H.* et al. Allogeneic vaccianation for renal cell carcinoma: development and monitoring. Bone Marrow Transplant. 25, 2, 83-87 (2000)
Bornkamm, G.W. & Jacobsen, N.R. Viral infections and antiviral immunity. Bone Marrow Transplant. 12, S88-S89 (1993)
Dörmer, P. & Gianni, A.M. Stem cell physiology - role of CD34. Bone Marrow Transplant. 12 (Suppl.4), 120-122 (1993)
Dörmér, P.G. & Gianni, A.M. Stem cell physiology - Role of CD34. Bone Marrow Transplant. 12, S120-S122 (1993)
Holler., E. ; Kolb, H.J. & Wilmanns, W. Treatment of GVHD-TNF-antibodies and related antagonists. Bone Marrow Transplant. 12, S29-S31 (1993)
Thierfelder, S.S. Antibody-induced suppression of graft versus host disease, animal models. Bone Marrow Transplant. 12, S6-S8 (1993)
Kolb, H.J. et al. Cancer after bone marrow transplantation. Bone Marrow Transplant. 10, 135-138 (1992)